yogesh waman
Venkata Palle, Sujay Basu, Yogesh Waman, Vidya Ramdas, Dinesh Barawkar, Meena Patel, Anil Panmand: Heterocyclic compounds as adenosine receptor antagonist. Advinus Therapeutics Pvt, K&L Gates, August 28, 2012: US08252797

Compounds of the present disclosure are fused pyrimidine compounds of formula (I), its tautomers, polymorphs, stereoisomers, prodrugs, solvate or a pharmaceutically acceptable salts thereof, as Adenosine receptor antagonists. Processes of their preparation are also described in the disclosure.


Richard T Lewis, Kevin J Merchant, Angus M MacLeod: Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them. Merck Sharp & Dohme, Robert J North, Melvin Winkour, May 7, 1996: US05514718 (250 worldwide citation)

Compounds of formula (I), and salts and prodrugs thereof ##STR1## wherein Q.sup.1 is halo substituted phenyl; naphthyl; indolyl; benzthiophenyl; benzofuranyl; benzyl; or fluorenyl;

Klaus Michael Dr, Mohr Peter Dr, Weiss Ekkehard Dr: Condensed heterocyclic compounds and their use in therapy.. Hoffmann La Roche, January 17, 1990: EP0350846-A2 (138 worldwide citation)

Compounds of the formula in which the symbols R, R, R, R, R, R, n, X and Y have the meaning indicated in the description, can be used as medicines for oncological and dermatological indications.


Michael Klaus, Peter Mohr, Ekkehard Weiss: Condensed heterocyclic compounds. Hoffmann La Roche, George M Gould, Bernard S Leon, William G Isgro, August 6, 1991: US05037825 (122 worldwide citation)

The invention relates to compounds of the formula ##STR1## wherein R.sup.1 is hydrogen, acyl, lower-alkyl or --CHO, --CH.sub.2 OR.sup.10, --COR.sup.7 or OR.sup.13 ; R.sup.2, R.sup.3 and R.sup.4 are, independently, hydrogen, lower-alkyl, lower-alkoxy or halogen; R.sup.5 and R.sup.6 are, independently ...



Klaus Michael Dr, Weiser Harald Dr, Loeliger Peter Dr: Heterocyclic compounds and rodenticides containing them.. Hoffmann La Roche, January 18, 1984: EP0098591-A1 (110 worldwide citation)

Verbindungen der allgemeinen Formel worin X -CH = CH-, -O- oder -S- ist; R ein Rest Ar-R oder -CH = CH-C(CH3) = CH-R; Ar Phenyl, Pyridyl, Furyl oder Thienyl; R ein Rest -CO2R , -C(O)R, -CH2OR , nieder-Alkylsulfonyl oder Formyl; R ein Rest -CO2R , -C(O)R, -CH2OR oder Formyl; R Wasserstoff oder nieder ...

Farina Marco, Gagliardi Stefania, Le, Poul Emmanuel, Palombi Giovanni, Rocher Jean Philippe: Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors. Addex Pharma, Farina Marco, Gagliardi Stefania, Le, Poul Emmanuel, Palombi Giovanni, Rocher Jean Philippe, DAVIES Jonathan Mark, December 7, 2006: WO/2006/129199 (109 worldwide citation)

The present invention relates to new compounds which are Heterocyclic derivatives of formula (I) wherein A, B, P, X, Y, Q, W, R1 and R2 are defined in the description. Invention compounds are useful for treating central or peripheral nervous system disorders and other disorders which are affected by ...